Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesis

Research output: Contribution to journalArticle

Authors

  • Houman Ashrafian
  • Linda O'Flaherty
  • Julie Adam
  • Violetta Steeples
  • Yuen-Li Chung
  • Phil East
  • Sakari Vanharanta
  • Heli Lehtonen
  • Emma Nye
  • Emine Hatipoglu
  • Melroy Miranda
  • Kimberley Howarth
  • Deepa Shukla
  • Helen Troy
  • John Griffiths
  • Bradley Spencer-Dene
  • Mohammed Yusuf
  • Emanuela Volpi
  • Patrick H Maxwell
  • Gordon Stamp
  • Richard Poulsom
  • Christopher W Pugh
  • Barbara Costa
  • Maria Flavia Di Renzo
  • Michael I Kotlikoff
  • Virpi Launonen
  • Lauri Aaltonen
  • Mona El-Bahrawy
  • Patrick J Pollard

Colleges, School and Institutes

External organisations

  • From the Division of Cardiovascular Medicine, British Heart Foundation Centre for Research Excellence, Radcliffe Department of Medicine, John Radcliffe Hospital, United Kingdom (E.M., D.J., J.P., P.C., K.M.C.); Wellcome Trust Centre for Human Genetics, Headington, Oxford, United Kingdom (E.M., J.P., P.C., K.M.C.); and Sir William Dunn School of Pathology, University of Oxford, United Kingdom (A.J.I., L.T., D.R.G.). eileen.mcneill@well.ox.ac.uk.

Abstract

Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is caused by mutations in the Krebs cycle enzyme fumarate hydratase (FH). It has been proposed that "pseudohypoxic" stabilization of hypoxia-inducible factor-α (HIF-α) by fumarate accumulation contributes to tumorigenesis in HLRCC. We hypothesized that an additional direct consequence of FH deficiency is the establishment of a biosynthetic milieu. To investigate this hypothesis, we isolated primary mouse embryonic fibroblast (MEF) lines from Fh1-deficient mice. As predicted, these MEFs upregulated Hif-1α and HIF target genes directly as a result of FH deficiency. In addition, detailed metabolic assessment of these MEFs confirmed their dependence on glycolysis, and an elevated rate of lactate efflux, associated with the upregulation of glycolytic enzymes known to be associated with tumorigenesis. Correspondingly, Fh1-deficient benign murine renal cysts and an advanced human HLRCC-related renal cell carcinoma manifested a prominent and progressive increase in the expression of HIF-α target genes and in genes known to be relevant to tumorigenesis and metastasis. In accord with our hypothesis, in a variety of different FH-deficient tissues, including a novel murine model of Fh1-deficient smooth muscle, we show a striking and progressive upregulation of a tumorigenic metabolic profile, as manifested by increased PKM2 and LDHA protein. Based on the models assessed herein, we infer that that FH deficiency compels cells to adopt an early, reversible, and progressive protumorigenic metabolic milieu that is reminiscent of that driving the Warburg effect. Targets identified in these novel and diverse FH-deficient models represent excellent potential candidates for further mechanistic investigation and therapeutic metabolic manipulation in tumors.

Details

Original languageEnglish
Pages (from-to)9153-65
Number of pages13
JournalCancer Research
Volume70
Issue number22
Publication statusPublished - 15 Nov 2010

Keywords

  • Animals, Carcinoma, Renal Cell/genetics, Cell Proliferation, Cells, Cultured, Embryo, Mammalian/cytology, Female, Fibroblasts/cytology, Fumarate Hydratase/deficiency, Gene Expression Profiling, Gene Expression Regulation, Enzymologic, Glycolysis, Humans, Hypoxia-Inducible Factor 1, alpha Subunit/genetics, Kidney Neoplasms/genetics, Leiomyomatosis/genetics, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Muscle, Smooth/metabolism, Neoplasms/genetics, Oligonucleotide Array Sequence Analysis, Reverse Transcriptase Polymerase Chain Reaction, Spectral Karyotyping